Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of fluorinated piperidine-based drugs. Its structure supports the creation of bioactive molecules with improved metabolic stability and binding affinity. Commonly employed in medicinal chemistry for optimizing drug candidates targeting central nervous system disorders and other therapeutic areas requiring enhanced pharmacokinetic properties. The tert-butyloxycarbonyl (Boc) protecting group allows for selective functionalization during multi-step syntheses.